ISCCM立场声明:重症结核病患者的评估与管理
结核病是全球重要致病和死亡原因,约3-4%的住院结核患者需入ICU,这些患者死亡率约50-60%。印度重症医学会(ISCCM)成立工作组,基于现有证据制定立场声明,涵盖重症患者结核分类、诊断检查、药物治疗、免疫抑制宿主结核、器官支持、感染控制和结核后遗症七个领域,共识别41个相关问题并生成循证立场声明,证据不足处基于共识推荐。该声明为ICU内结核病患者的评估与管理提供指导。
要点
- 约3-4%的住院结核患者需入ICU,这些患者死亡率约50-60%。
- ISCCM工作组识别七个领域:重症结核分类、诊断检查、药物治疗、免疫抑制宿主结核、器官支持、感染控制、结核后遗症。
- 共提出41个相关问题,有证据处生成循证立场声明,无证据处基于共识推荐。
适用人群与场景
- 需入住ICU的结核病患者(约占住院结核患者的3-4%)。
研究设计与关键结果
- ISCCM成立工作组制定立场声明,识别七个领域(重症结核分类、诊断检查、药物治疗、免疫抑制宿主结核、器官支持、感染控制、结核后遗症),提出41个问题,有证据处生成循证立场声明,证据不足处基于共识推荐。
证据类型、等级与局限
- 证据类型:学会立场声明(指南/共识),由印度重症医学会(ISCCM)工作组制定,基于现有证据生成立场声明,证据不足处基于共识。
- 局限:原文未报告局限性
对床旁实践的改变
- 该立场声明指导ICU内结核病患者的评估与管理。
指南或共识出处
- ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis. Indian J Crit Care Med 2024;28(S2):S67-S91.
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Tuberculosis (TB) is an important cause of morbidity and mortality globally. About 3-4% of hospitalized TB patients require admission to the intensive care unit (ICU); the mortality in these patients is around 50-60%. There is limited literature on the evaluation and management of patients with TB who required ICU admission. The Indian Society of Critical Care Medicine (ISCCM) constituted a working group to develop a position paper that provides recommendations on the various aspects of TB in the ICU setting based on available evidence. Seven domains were identified including the categorization of TB in the critically ill, diagnostic workup, drug therapy, TB in the immunocompromised host, organ support, infection control, and post-TB sequelae. Forty-one questions pertaining to these domains were identified and evidence-based position statements were generated, where available, keeping in focus the critical care aspects. Where evidence was not available, the recommendations were based on consensus. This position paper guides the approach to and management of critically ill patients with TB.
HOW TO CITE THIS ARTICLE: Chacko B, Chaudhry D, Peter JV, Khilnani G, Saxena P, Sehgal IS, et al. isccm Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis. Indian J Crit Care Med 2024;28(S2):S67-S91.
参考来源
- Chacko B, Chaudhry D, Peter JV, et al. ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis. Indian J Crit Care Med. 2024. PMID: 39234233. doi:10.5005/jp-journals-10071-24783
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。